<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32745677</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9572</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><PubDate><Year>2020</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>NeuroImage</Title><ISOAbbreviation>Neuroimage</ISOAbbreviation></Journal><ArticleTitle>Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>117216</StartPage><MedlinePgn>117216</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">117216</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroimage.2020.117216</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-8119(20)30702-3</ELocationID><Abstract><AbstractText>Susceptibility weighted magnetic resonance imaging (MRI) is sensitive to the local concentration of iron and myelin. Here, we describe a robust image processing pipeline for quantitative susceptibility mapping (QSM) and R2* mapping of fixed post-mortem, whole-brain data. Using this pipeline, we compare the resulting quantitative maps in brains from patients with amyotrophic lateral sclerosis (ALS) and controls, with validation against iron and myelin histology. Twelve post-mortem brains were scanned with a multi-echo gradient echo sequence at 7T, from which susceptibility and R2* maps were generated. Semi-quantitative histological analysis for ferritin (the principal iron storage protein) and myelin proteolipid protein was performed in the primary motor, anterior cingulate and visual cortices. Magnetic susceptibility and R2* values in primary motor cortex were higher in ALS compared to control brains. Magnetic susceptibility and R2* showed positive correlations with both myelin and ferritin estimates from histology. Four out of nine ALS brains exhibited clearly visible hyperintense susceptibility and R2* values in the primary motor cortex. Our results demonstrate the potential for MRI-histology studies in whole, fixed post-mortem brains to investigate the biophysical source of susceptibility weighted MRI signals in neurodegenerative diseases like ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chaoyue</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom. Electronic address: chaoyue.wang@ndcn.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foxley</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom; Department of Radiology, University of Chicago, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansorge</LastName><ForeName>Olaf</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangerter-Christensen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom; Brigham Young University, Provo, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiew</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonte</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom; University of Groningen,the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menke</LastName><ForeName>Ricarda Al</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollink</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom; Department of Anatomy, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallebage-Gamarallage</LastName><ForeName>Menuka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom; Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Karla L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tendler</LastName><ForeName>Benjamin C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G1000691</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>202788/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L022656/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K02213X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>203139/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroimage</MedlineTA><NlmUniqueID>9215515</NlmUniqueID><ISSNLinking>1053-8119</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-73-2</RegistryNumber><NameOfSubstance UI="D005293">Ferritins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003933" MajorTopicYN="N">Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005293" MajorTopicYN="Y">Ferritins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006179" MajorTopicYN="N">Gyrus Cinguli</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009186" MajorTopicYN="Y">Myelin Sheath</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014793" MajorTopicYN="N">Visual Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Ferritin</Keyword><Keyword MajorTopicYN="N">Myelin</Keyword><Keyword MajorTopicYN="N">Post-mortem</Keyword><Keyword MajorTopicYN="N">Quantitative susceptibility mapping</Keyword><Keyword MajorTopicYN="N">R2* mapping</Keyword></KeywordList><CoiStatement>Declarations of Competing Interest None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32745677</ArticleId><ArticleId IdType="pmc">PMC7775972</ArticleId><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117216</ArticleId><ArticleId IdType="pii">S1053-8119(20)30702-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acosta-Cabronero J. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology. 2018;289(1):195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166868</ArticleId><ArticleId IdType="pubmed">30040038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein M.A. Reconstructions of phase contrast, phased array multicoil data. Magn. Reson. Med. 1994;32(3):330&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">7984065</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74(1):20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M. Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. NeuroImage: Clin. 2016;12:965&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153607</ArticleId><ArticleId IdType="pubmed">27995062</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawe R.J. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn. Reson. Med. 2009;61(4):810&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713761</ArticleId><ArticleId IdType="pubmed">19189294</ArticleId></ArticleIdList></Reference><Reference><Citation>Deistung A. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2-imaging at ultra-high magnetic field strength. Neuroimage. 2013;65:299&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">23036448</ArticleId></ArticleIdList></Reference><Reference><Citation>Durrant C., Hertzberg M., Kuchel P. Magnetic susceptibility: further insights into macroscopic and microscopic fields and the sphere of Lorentz. Concepts Magn. Reson. Part A. 2003;18(1):72&#x2013;95.</Citation></Reference><Reference><Citation>Duyn J. MR susceptibility imaging. J. Magn. Reson. 2013;229:198&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3602381</ArticleId><ArticleId IdType="pubmed">23273840</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.U., Tomasi D., Caparelli E.C. Magnetic field shift due to mechanical vibration in functional magnetic resonance imaging. Magn. Reson. Med. 2005;54(5):1261&#x2013;1267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2408718</ArticleId><ArticleId IdType="pubmed">16215962</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunaga M. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. 2010;107(8):3834&#x2013;3839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840419</ArticleId><ArticleId IdType="pubmed">20133720</ArticleId></ArticleIdList></Reference><Reference><Citation>Geijs D.J. Medical Imaging 2018: Digital Pathology. International Society for Optics and Photonics.&lt;/; 2018. Automatic color unmixing of IHC stained whole slide images.</Citation></Reference><Reference><Citation>Glasser M.F. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536(7615):171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990127</ArticleId><ArticleId IdType="pubmed">27437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Greve D.N., Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage. 2009;48(1):63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2733527</ArticleId><ArticleId IdType="pubmed">19573611</ArticleId></ArticleIdList></Reference><Reference><Citation>Haacke E. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J. Magn. Reson. Imaging. 2010;32(3):663&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2933933</ArticleId><ArticleId IdType="pubmed">20815065</ArticleId></ArticleIdList></Reference><Reference><Citation>Haacke E.M. Quantitative susceptibility mapping: current status and future directions. Magn. Reson. Imaging. 2015;33(1):1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">25267705</ArticleId></ArticleIdList></Reference><Reference><Citation>Hametner S. The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation-A biochemical and histological validation study. Neuroimage. 2018;179:117&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">29890327</ArticleId></ArticleIdList></Reference><Reference><Citation>He T. A phantom study of temperature-dependent MRI T2* measurement. J. Cardiovasc. Magn. Reson. 2009;11(S1):P147.</Citation></Reference><Reference><Citation>Huszar I.N. Tensor image registration library: automated non-linear registration of sparsely sampled histological specimens to post-mortem MRI of the whole human brain. bioRxiv. 2019</Citation></Reference><Reference><Citation>Jenkinson M. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">12377157</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M. Fast, automated, N&#x2010;dimensional phase&#x2010;unwrapping algorithm. Magn. Reson. Med. 2003;49(1):193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">12509838</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001;5(2):143&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">11516708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kressler B. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans. Med. Imaging. 2009;29(2):273&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874210</ArticleId><ArticleId IdType="pubmed">19502123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan J.Y. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PloS One. 2012;7(4):e35241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Langkammer C. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology. 2010;257(2):455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">20843991</ArticleId></ArticleIdList></Reference><Reference><Citation>Langkammer C. Susceptibility induced gray&#x2013;white matter MRI contrast in the human brain. Neuroimage. 2012;59(2):1413&#x2013;1419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3236994</ArticleId><ArticleId IdType="pubmed">21893208</ArticleId></ArticleIdList></Reference><Reference><Citation>Langkammer C. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage. 2012;62(3):1593&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413885</ArticleId><ArticleId IdType="pubmed">22634862</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Wu B., Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage. 2011;55(4):1645&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3062654</ArticleId><ArticleId IdType="pubmed">21224002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage. 2011;56(3):930&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3085608</ArticleId><ArticleId IdType="pubmed">21320606</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage. 2012;59(3):2560&#x2013;2568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3254812</ArticleId><ArticleId IdType="pubmed">21925276</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T. A novel background field removal method for MRI using projection onto dipole fields. NMR Biomed. 2011;24(9):1129&#x2013;1136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628923</ArticleId><ArticleId IdType="pubmed">21387445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn. Reson. Med. 2013;69(2):467&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">22488774</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques, J., Bowtell, R., 2005. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn. Reson. 25B, 65&#x2013;78. doi:10.1002/cmr.b.20034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmr.b.20034</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadowcroft M.D. Histological&#x2013;MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis. J. Magn. Reson. Imaging. 2015;41(3):665&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145061</ArticleId><ArticleId IdType="pubmed">24615949</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K.L. Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage. 2011;57(1):167&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3115068</ArticleId><ArticleId IdType="pubmed">21473920</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwenhuys R., Broere C.A. A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf. Brain Structure and Function. 2017;222(1):465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5225164</ArticleId><ArticleId IdType="pubmed">27138385</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsu N. A threshold selection method from gray-level histograms. IEEE Trans. Syst., Man, Cybern. 1979;9(1):62&#x2013;66.</Citation></Reference><Reference><Citation>Pallebage-Gamarallage M. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. BMC Neurosci. 2018;19(1):11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5848544</ArticleId><ArticleId IdType="pubmed">29529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F. Proceedings of the 25th Annual Meeting of ISMRM. 2017. Correction of fixation effects in post-mortem T2 measurements using a kinetic tensor model; p. 3728.</Citation></Reference><Reference><Citation>Reinert A. Iron concentrations in neurons and glial cells with estimates on ferritin concentrations. BMC Neurosci. 2019;20(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6542065</ArticleId><ArticleId IdType="pubmed">31142282</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson S.D. Combining phase images from array coils using a short echo time reference scan (COMPOSER) Magn. Reson. Med.e. 2017;77(1):318&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217082</ArticleId><ArticleId IdType="pubmed">26712454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer A.D. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. Am. J. Roentgenol. 2015;204(5):1086&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4889122</ArticleId><ArticleId IdType="pubmed">25905946</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweser F. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010;37(10):5165&#x2013;5178.</Citation><ArticleIdList><ArticleId IdType="pubmed">21089750</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweser F. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage. 2011;54(4):2789&#x2013;2807.</Citation><ArticleIdList><ArticleId IdType="pubmed">21040794</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmueli K. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009;62(6):1510&#x2013;1522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4275127</ArticleId><ArticleId IdType="pubmed">19859937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H. Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. Neuroimage. 2015;105:486&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">25462797</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R.H. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain. 2015;138(10):3110&#x2013;3122.</Citation><ArticleIdList><ArticleId IdType="pubmed">26231953</ArticleId></ArticleIdList></Reference><Reference><Citation>Tendler B.C., Bowtell R. Frequency difference mapping applied to the corpus callosum at 7T. Magn. Reson. Med. 2019;81(5):3017&#x2013;3031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6492142</ArticleId><ArticleId IdType="pubmed">30582226</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner R. Myelin and modeling: Bootstrapping cortical microcircuits. Front. Neural Circuits. 2019;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6517540</ArticleId><ArticleId IdType="pubmed">31133821</ArticleId></ArticleIdList></Reference><Reference><Citation>van Duijn S. Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease. J. Histochem. Cytochem. 2013;61(11):785&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3808575</ArticleId><ArticleId IdType="pubmed">23887894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y., Quantitative susceptibility mapping: magnetic resonance imaging of tissue magnetism. 2013: CreateSpace.</Citation></Reference><Reference><Citation>Wang Y., Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn. Reson. Med. 2015;73(1):82&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297605</ArticleId><ArticleId IdType="pubmed">25044035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range. NMR Biomed. 2015;28(10):1294&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4572914</ArticleId><ArticleId IdType="pubmed">26313885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wharton S., Sch&#xe4;fer A., Bowtell R. Susceptibility mapping in the human brain using threshold-based k-space division. Magn. Reson. Med. 2010;63(5):1292&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">20432300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yablonskiy D.A. Quantitation of intrinsic magnetic susceptibility-related effects in a tissue matrix. Phantom study. Magn. Reson. Med. 1998;39(3):417&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">9498598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yablonskiy D.A., Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994;32(6):749&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">7869897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. Quantitative susceptibility mapping and R2* measured changes during white matter lesion development in multiple sclerosis: myelin breakdown, myelin debris degradation and removal, and iron accumulation. Am. J. Neuroradiol. 2016;37(9):1629&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018433</ArticleId><ArticleId IdType="pubmed">27256856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W. Imaging of stroke: a comparison between X-ray fluorescence and magnetic resonance imaging methods. Magn. Reson. Imaging. 2012;30(10):1416&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843005</ArticleId><ArticleId IdType="pubmed">22789844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage. 2013;78:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843006</ArticleId><ArticleId IdType="pubmed">23591072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D. Background field removal by solving the Laplacian boundary value problem. NMR Biomed. 2014;27(3):312&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">24395595</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>